# mRNA 3′ UTRs direct microRNA degradation to participate in imprinted gene networks and regulate growth

**Authors:** Daniel H. Lin, Lara E. Elcavage, Ekaterina Khalizeva, David P. Bartel

PMC · DOI: 10.1101/gad.353479.125 · Genes & Development · 2026-04-01

## TL;DR

This study shows how mRNA 3′ UTRs trigger microRNA degradation, linking this process to imprinted gene networks and growth regulation in mice.

## Contribution

The paper identifies new TDMD-triggering sites and demonstrates their role in imprinted gene networks and growth.

## Key findings

- Five new TDMD-triggering sites were identified and validated in mouse models.
- Collaborative TDMD sites in the same or different transcripts can destabilize microRNAs.
- TDMD of miR-322 and miR-503 by Plagl1 and Lrrc58 promotes growth in mice.

## Abstract

In this study, Lin et al. identify trigger RNAs that drive target-directed microRNA degradation (TDMD) of ZSWIM8-sensitive microRNA. They describe instances in which multiple trigger RNAs or TDMD sites can collaboratively destabilize a miRNA, as well as highlight a link between the TDMD pathway and genomic imprinting.

MicroRNAs direct downregulation of target mRNAs. Sometimes, however, this regulatory paradigm inverts, and a target RNA triggers degradation of a microRNA. This target-directed microRNA degradation (TDMD) requires ZSWIM8. Zswim8−/− mice exhibit reduced growth and perinatal lethality, accompanied by stabilization of >40 microRNAs. Nonetheless, studies of TDMD function in mammals have been limited because only two TDMD-triggering RNAs have been identified in mice. Here, we computationally identify and validate five new TDMD-triggering sites in mouse models. One site in Atp6v1g1 and two sites in Lpar4 direct degradation of miR-335-3p, showing that in mammals, two sites in the same transcript and multiple sites in different transcripts can collaborate to destabilize a microRNA. Moreover, sites in Plagl1 and Lrrc58 direct degradation of miR-322 and miR-503, respectively. Mice lacking the Plagl1 and Lrrc58 sites were smaller, demonstrating that target-directed degradation of miR-322 and miR-503 promotes growth. Both miR-335-3p and Plagl1 are maternally imprinted, implying their participation in parental conflict, but their corresponding triggers or target microRNA partners are not imprinted. Thus, 3′ UTRs can participate in parental conflict not only by regulating protein production but also by engaging TDMD to access an additional layer of regulation within a network of imprinted and biallelic genes.

## Linked entities

- **Genes:** ZSWIM8 (zinc finger SWIM-type containing 8) [NCBI Gene 23053], ATP6V1G1 (ATPase H+ transporting V1 subunit G1) [NCBI Gene 9550], LPAR4 (lysophosphatidic acid receptor 4) [NCBI Gene 2846], PLAGL1 (PLAG1 like zinc finger 1) [NCBI Gene 5325], LRRC58 (leucine rich repeat containing 58) [NCBI Gene 116064]
- **Proteins:** ZSWIM8 (zinc finger SWIM-type containing 8)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ago2 (argonaute RISC catalytic subunit 2) [NCBI Gene 239528] {aka 1110029L17Rik, 2310051F07Rik, Eif2c2, Gerp95, Gm10365, mKIAA4215}, Igf2 (insulin-like growth factor 2) [NCBI Gene 16002] {aka Igf-2, Igf-II, M6pr, Mpr, Peg2}, Nrep (neuronal regeneration related protein) [NCBI Gene 27528] {aka D0H4S114, Harp, P311, PTZ17, SEZ17}, Dnah8 (dynein, axonemal, heavy chain 8) [NCBI Gene 13417] {aka ATPase, Dnahc8, Hst6.7b, P1-Loop}, H19 (H19, imprinted maternally expressed transcript) [NCBI Gene 14955] {aka EyeLinc6}, Mir322 (microRNA 322) [NCBI Gene 723907] {aka Mirn322, mmu-mir-322}, Bcl2l11 (BCL2 like 11) [NCBI Gene 12125] {aka 1500006F24Rik, Bim, Bod, bcl2-L-11}, Plagl1 (pleiomorphic adenoma gene-like 1) [NCBI Gene 22634] {aka 2610311E24Rik, Lot1, Zac1}, Gnas (GNAS complex locus) [NCBI Gene 14683] {aka 5530400H20Rik, A930027G11Rik, C130027O20Rik, GPSA, GSP, Galphas}, Lpar4 (lysophosphatidic acid receptor 4) [NCBI Gene 78134] {aka 5730485F04Rik, Gpr23, LPA4, p2y9}, PLAGL1 (PLAG1 like zinc finger 1) [NCBI Gene 5325] {aka LOT1, ZAC, ZAC1}, Igf1r (insulin-like growth factor I receptor) [NCBI Gene 16001] {aka A330103N21Rik, CD221, D930020L01, IGF-1R, hyft}, Eloc (elongin C) [NCBI Gene 67923] {aka 2610043E24Rik, 2610301I15Rik, Tceb1}, Tnrc6a (trinucleotide repeat containing 6a) [NCBI Gene 233833] {aka 2010321I05Rik, 3110054G10Rik, CAGH26, D130023A07Rik, GW182, Tnrc6}, mir-35 (ncRNA) [NCBI Gene 260178], Elob (elongin B) [NCBI Gene 67673] {aka 0610040H15Rik, Tceb2}, Oip5os1 (Opa interacting protein 5, opposite strand 1) [NCBI Gene 66602] {aka 1190006L01Rik, 1700020I14Rik, 4933437I03Rik, Cyrano, Oip5as1, linc-oip5}, Gpr34 (G protein-coupled receptor 34) [NCBI Gene 23890] {aka Lypsr1}, ZIM3 (zinc finger imprinted 3) [NCBI Gene 114026] {aka ZNF657}, Mirg (miRNA containing gene) [NCBI Gene 100040724] {aka 2810474H01Rik, Gm2928, Meg9, mir-410}, Cdc25a (cell division cycle 25A) [NCBI Gene 12530] {aka D9Ertd393e}, MIR335 (microRNA 335) [NCBI Gene 442904] {aka MIRN335, hsa-mir-335, miRNA335, mir-335}, LPAR4 (lysophosphatidic acid receptor 4) [NCBI Gene 2846] {aka GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9}, NEB (nebulin) [NCBI Gene 4703] {aka AMC6, NEB177D, NEM2}, LRRC58 (leucine rich repeat containing 58) [NCBI Gene 116064], MIR424 (microRNA 424) [NCBI Gene 494336] {aka MIR322, MIRN424, hsa-mir-424, miRNA424, mir-424}, ATP6V1G1 (ATPase H+ transporting V1 subunit G1) [NCBI Gene 9550] {aka ATP6G, ATP6G1, ATP6GL, ATP6J, Vma10}, Serpine1 (serine (or cysteine) peptidase inhibitor, clade E, member 1) [NCBI Gene 18787] {aka PAI-1, PAI1, Planh1}, Mir503 (microRNA 503) [NCBI Gene 723879] {aka Mirn503, mmu-mir-503}, MIR503 (microRNA 503) [NCBI Gene 574506] {aka MIRN503, hsa-mir-503, mir-503}, MIR4275 (microRNA 4275) [NCBI Gene 100422937], Cul3 (cullin 3) [NCBI Gene 26554] {aka KIAA0617}, MEST (mesoderm specific transcript) [NCBI Gene 4232] {aka PEG1}, Atp6v1g1 [NCBI Gene 100712974], Cdk6 (cyclin dependent kinase 6) [NCBI Gene 12571] {aka Crk2}, Mir351 (microRNA 351) [NCBI Gene 723910] {aka Mirn351, mmu-mir-351}, Cdkn1c (cyclin dependent kinase inhibitor 1C) [NCBI Gene 12577] {aka CDKI, Kip2, p57(kip2), p57Kip2}, Lrrc58 (leucine rich repeat containing 58) [NCBI Gene 320184] {aka 1810012N18Rik, C330018J07Rik}, Mir16-1 (microRNA 16-1) [NCBI Gene 387134] {aka Mirn16, Mirn16-1, miR-16, mir-16-1}, Mir335 (microRNA 335) [NCBI Gene 723930] {aka Mirn335, mir-335, mmu-mir-335}, mir-7 (mir-7 stem loop) [NCBI Gene 12798133] {aka 7, CR33042, CR42883, Dmel\CR42883, Dmel_CR33042, dme-miR-7}, Ccne1 (cyclin E1) [NCBI Gene 12447] {aka CycE1}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, Atp6v1g1 (ATPase, H+ transporting, lysosomal V1 subunit G1) [NCBI Gene 66290] {aka 1810024D14Rik, ATP6J, Atp6g1, VAG1, Vma10}, ZSWIM8 (zinc finger SWIM-type containing 8) [NCBI Gene 23053] {aka KIAA0913}, Mir542 (microRNA 542) [NCBI Gene 723901] {aka Mirn542, mir-542, mmu-mir-542}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, Mul1 (mitochondrial ubiquitin ligase activator of NFKB 1) [NCBI Gene 68350] {aka 0610009K11Rik, Gide, Tnrip-1}, Mest (mesoderm specific transcript) [NCBI Gene 17294] {aka Peg1}, Zswim8 (zinc finger SWIM-type containing 8) [NCBI Gene 268721] {aka 2310021P13Rik, 4832404P21Rik, Kiaa0913, mKIAA0913}
- **Diseases:** cancer (MESH:D009369), heart and lung development defects (MESH:C535708), embryonic growth defect (MESH:D006130), defects (MESH:D000013), TDMD (MESH:D055959), intrauterine growth restriction (MESH:D005317), developmental defects (MESH:D000094602), perinatal lethality (MESH:C564306)
- **Chemicals:** penicillin (MESH:D010406), cysteine (MESH:D003545), polyethylene glycol (MESH:D011092), PBS (MESH:D007854), 1-bromo-3-chloropropane (MESH:C560814), hygromycin B (MESH:D006921), water (MESH:D014867), isopropanol (MESH:D019840), polyacrylamide (MESH:C016679), N2 (MESH:D009584), urea (MESH:D014508), puromycin (MESH:D011691), PEG 8000 (MESH:C000595216), formamide (MESH:C031066), CO2 (MESH:D002245), ethanol (MESH:D000431), N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (MESH:C569779), chloroform (MESH:D002725), Lipofectamine 2000 (MESH:C086724), acrylamide (MESH:D020106), streptomycin (MESH:D013307), polybrene (MESH:D006583), Dora (-), 1-methylimidazole (MESH:C018100), SDS (MESH:D012967), EDC (MESH:C024565)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Thermococcus celericrescens (species) [taxon 227598], Muridae (family) [taxon 10066], Cercopithecidae (monkey, family) [taxon 9527], Caenorhabditis elegans (species) [taxon 6239], Mus musculus (house mouse, species) [taxon 10090], Drosophila melanogaster (fruit fly, species) [taxon 7227], C. elegans [taxon 328850], Homo sapiens (human, species) [taxon 9606], Cavia porcellus (domestic guinea pig, species) [taxon 10141], Diptera (flies, order) [taxon 7147], Xenopus tropicalis (tropical clawed frog, species) [taxon 8364]
- **Cell lines:** Lrrc58, 1 — Homo sapiens (Human), Gastric signet ring cell adenocarcinoma, Cancer cell line (CVCL_XG63), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), IMR90 — Homo sapiens (Human), Finite cell line (CVCL_0347), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), BJ — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_6573), MEF — Mus musculus (Mouse), Finite cell line (CVCL_9115), HFF-1 — Homo sapiens (Human), Finite cell line (CVCL_3285), CRISPRi — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_VM40)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13041716/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13041716/full.md

## References

91 references — full list in the complete paper: https://tomesphere.com/paper/PMC13041716/full.md

---
Source: https://tomesphere.com/paper/PMC13041716